nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloroquine—CYP1A1—Dacarbazine—skin cancer	0.124	0.164	CbGbCtD
Chloroquine—CYP2C8—Vismodegib—skin cancer	0.118	0.156	CbGbCtD
Chloroquine—ABCB1—Vismodegib—skin cancer	0.08	0.106	CbGbCtD
Chloroquine—CYP3A4—Temozolomide—skin cancer	0.0692	0.0912	CbGbCtD
Chloroquine—CYP3A4—Imiquimod—skin cancer	0.0692	0.0912	CbGbCtD
Chloroquine—CYP2D6—Vemurafenib—skin cancer	0.0596	0.0786	CbGbCtD
Chloroquine—CYP3A4—Vismodegib—skin cancer	0.0479	0.0632	CbGbCtD
Chloroquine—ABCB1—Dactinomycin—skin cancer	0.042	0.0554	CbGbCtD
Chloroquine—CYP2C8—Fluorouracil—skin cancer	0.042	0.0554	CbGbCtD
Chloroquine—CYP3A4—Vemurafenib—skin cancer	0.0379	0.05	CbGbCtD
Chloroquine—CYP3A5—Docetaxel—skin cancer	0.0333	0.044	CbGbCtD
Chloroquine—ABCB1—Docetaxel—skin cancer	0.0217	0.0286	CbGbCtD
Chloroquine—CYP3A4—Docetaxel—skin cancer	0.013	0.0172	CbGbCtD
Chloroquine—TLR9—TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling—TLR7—skin cancer	0.013	0.18	CbGpPWpGaD
Chloroquine—TLR9—Trafficking and processing of endosomal TLR—TLR7—skin cancer	0.0114	0.158	CbGpPWpGaD
Chloroquine—Hydroxychloroquine—TLR7—skin cancer	0.00946	0.578	CrCbGaD
Chloroquine—Primaquine—KRT7—skin cancer	0.00543	0.332	CrCbGaD
Chloroquine—Cardiomyopathy—Imiquimod—skin cancer	0.00457	0.0298	CcSEcCtD
Chloroquine—Electrocardiogram change—Fluorouracil—skin cancer	0.00452	0.0295	CcSEcCtD
Chloroquine—Polyneuropathy—Docetaxel—skin cancer	0.00286	0.0186	CcSEcCtD
Chloroquine—Reaction gastrointestinal—Docetaxel—skin cancer	0.00279	0.0182	CcSEcCtD
Chloroquine—Cardiomyopathy—Fluorouracil—skin cancer	0.00253	0.0164	CcSEcCtD
Chloroquine—Eruption—Dactinomycin—skin cancer	0.00252	0.0164	CcSEcCtD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TLR7—skin cancer	0.00251	0.0348	CbGpPWpGaD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TLR7—skin cancer	0.00246	0.0342	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TLR7—skin cancer	0.00237	0.033	CbGpPWpGaD
Chloroquine—Photosensitivity—Vemurafenib—skin cancer	0.00227	0.0148	CcSEcCtD
Chloroquine—Skin exfoliation—Imiquimod—skin cancer	0.00223	0.0146	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.00219	0.0304	CbGpPWpGaD
Chloroquine—Myopathy—Temozolomide—skin cancer	0.002	0.013	CcSEcCtD
Chloroquine—Alopecia—Vismodegib—skin cancer	0.00197	0.0128	CcSEcCtD
Chloroquine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00186	0.0121	CcSEcCtD
Chloroquine—Scotoma—Temozolomide—skin cancer	0.00185	0.012	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Imiquimod—skin cancer	0.0018	0.0117	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00179	0.0117	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.00171	0.0237	CbGpPWpGaD
Chloroquine—Eosinophilia—Vemurafenib—skin cancer	0.0017	0.0111	CcSEcCtD
Chloroquine—TLR9—Toll-Like Receptors Cascades—TLR7—skin cancer	0.00169	0.0234	CbGpPWpGaD
Chloroquine—Skin exfoliation—Bleomycin—skin cancer	0.00159	0.0103	CcSEcCtD
Chloroquine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00157	0.0102	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00152	0.00991	CcSEcCtD
Chloroquine—Eruption—Docetaxel—skin cancer	0.00152	0.00988	CcSEcCtD
Chloroquine—Cinchocaine—SCN10A—skin cancer	0.00148	0.0903	CrCbGaD
Chloroquine—Hearing impaired—Temozolomide—skin cancer	0.00147	0.0096	CcSEcCtD
Chloroquine—Aplastic anaemia—Dactinomycin—skin cancer	0.00146	0.00948	CcSEcCtD
Chloroquine—Pancytopenia—Imiquimod—skin cancer	0.00139	0.00908	CcSEcCtD
Chloroquine—Decreased appetite—Vismodegib—skin cancer	0.00138	0.00897	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00137	0.00891	CcSEcCtD
Chloroquine—Photosensitivity reaction—Imiquimod—skin cancer	0.00134	0.00873	CcSEcCtD
Chloroquine—Skin exfoliation—Temozolomide—skin cancer	0.00134	0.00872	CcSEcCtD
Chloroquine—Aplastic anaemia—Temozolomide—skin cancer	0.00132	0.00858	CcSEcCtD
Chloroquine—Erythema multiforme—Vemurafenib—skin cancer	0.0013	0.00849	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.0013	0.00846	CcSEcCtD
Chloroquine—Abdominal pain—Vismodegib—skin cancer	0.00125	0.00816	CcSEcCtD
Chloroquine—TNF—Adipogenesis—ASIP—skin cancer	0.00125	0.0173	CbGpPWpGaD
Chloroquine—Scotoma—Docetaxel—skin cancer	0.00123	0.008	CcSEcCtD
Chloroquine—Alopecia—Vemurafenib—skin cancer	0.00122	0.00793	CcSEcCtD
Chloroquine—Asthenia—Vismodegib—skin cancer	0.00114	0.00741	CcSEcCtD
Chloroquine—Visual impairment—Imiquimod—skin cancer	0.00113	0.00738	CcSEcCtD
Chloroquine—Pruritus—Vismodegib—skin cancer	0.00112	0.0073	CcSEcCtD
Chloroquine—Erythema multiforme—Imiquimod—skin cancer	0.00111	0.00724	CcSEcCtD
Chloroquine—Tinnitus—Imiquimod—skin cancer	0.0011	0.00714	CcSEcCtD
Chloroquine—Diarrhoea—Vismodegib—skin cancer	0.00108	0.00706	CcSEcCtD
Chloroquine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00108	0.00703	CcSEcCtD
Chloroquine—Photosensitivity—Fluorouracil—skin cancer	0.00107	0.00696	CcSEcCtD
Chloroquine—Alopecia—Imiquimod—skin cancer	0.00104	0.00677	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00101	0.0066	CcSEcCtD
Chloroquine—Vomiting—Vismodegib—skin cancer	0.00101	0.00656	CcSEcCtD
Chloroquine—Rash—Vismodegib—skin cancer	0.000999	0.00651	CcSEcCtD
Chloroquine—Pancytopenia—Bleomycin—skin cancer	0.000991	0.00645	CcSEcCtD
Chloroquine—Hearing impaired—Docetaxel—skin cancer	0.00098	0.00638	CcSEcCtD
Chloroquine—Anaphylactic shock—Vemurafenib—skin cancer	0.000979	0.00638	CcSEcCtD
Chloroquine—Nausea—Vismodegib—skin cancer	0.000941	0.00613	CcSEcCtD
Chloroquine—Agitation—Imiquimod—skin cancer	0.00094	0.00612	CcSEcCtD
Chloroquine—Angioedema—Imiquimod—skin cancer	0.000935	0.00609	CcSEcCtD
Chloroquine—Pancytopenia—Dactinomycin—skin cancer	0.000924	0.00602	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000917	0.00597	CcSEcCtD
Chloroquine—Hypotension—Vemurafenib—skin cancer	0.000915	0.00596	CcSEcCtD
Chloroquine—Neutropenia—Dactinomycin—skin cancer	0.00091	0.00593	CcSEcCtD
Chloroquine—Skin exfoliation—Docetaxel—skin cancer	0.00089	0.0058	CcSEcCtD
Chloroquine—Convulsion—Imiquimod—skin cancer	0.000886	0.00577	CcSEcCtD
Chloroquine—TNF—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.000884	0.0123	CbGpPWpGaD
Chloroquine—Anxiety—Imiquimod—skin cancer	0.000868	0.00565	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00086	0.0056	CcSEcCtD
Chloroquine—Decreased appetite—Vemurafenib—skin cancer	0.000851	0.00554	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000845	0.00551	CcSEcCtD
Chloroquine—Pancytopenia—Temozolomide—skin cancer	0.000836	0.00544	CcSEcCtD
Chloroquine—Neutropenia—Temozolomide—skin cancer	0.000823	0.00536	CcSEcCtD
Chloroquine—Agranulocytosis—Dactinomycin—skin cancer	0.00081	0.00527	CcSEcCtD
Chloroquine—Photosensitivity reaction—Temozolomide—skin cancer	0.000803	0.00523	CcSEcCtD
Chloroquine—Eosinophilia—Fluorouracil—skin cancer	0.000803	0.00523	CcSEcCtD
Chloroquine—Anorexia—Imiquimod—skin cancer	0.000796	0.00518	CcSEcCtD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—TLR7—skin cancer	0.000796	0.0111	CbGpPWpGaD
Chloroquine—Hepatitis—Dactinomycin—skin cancer	0.000779	0.00507	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000778	0.00507	CcSEcCtD
Chloroquine—Pancytopenia—Fluorouracil—skin cancer	0.00077	0.00502	CcSEcCtD
Chloroquine—TNF—Adipogenesis—PLIN2—skin cancer	0.000756	0.0105	CbGpPWpGaD
Chloroquine—Insomnia—Imiquimod—skin cancer	0.000755	0.00492	CcSEcCtD
Chloroquine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00074	0.00482	CcSEcCtD
Chloroquine—Alopecia—Bleomycin—skin cancer	0.000738	0.00481	CcSEcCtD
Chloroquine—Erythema multiforme—Dactinomycin—skin cancer	0.000736	0.0048	CcSEcCtD
Chloroquine—Decreased appetite—Imiquimod—skin cancer	0.000726	0.00473	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000721	0.0047	CcSEcCtD
Chloroquine—Visual disturbance—Docetaxel—skin cancer	0.000714	0.00465	CcSEcCtD
Chloroquine—Hepatitis—Temozolomide—skin cancer	0.000704	0.00459	CcSEcCtD
Chloroquine—Asthenia—Vemurafenib—skin cancer	0.000702	0.00458	CcSEcCtD
Chloroquine—Hallucination—Temozolomide—skin cancer	0.000701	0.00456	CcSEcCtD
Chloroquine—Pruritus—Vemurafenib—skin cancer	0.000693	0.00451	CcSEcCtD
Chloroquine—Alopecia—Dactinomycin—skin cancer	0.000688	0.00448	CcSEcCtD
Chloroquine—Feeling abnormal—Imiquimod—skin cancer	0.000688	0.00448	CcSEcCtD
Chloroquine—Visual impairment—Temozolomide—skin cancer	0.000679	0.00442	CcSEcCtD
Chloroquine—Agranulocytosis—Fluorouracil—skin cancer	0.000675	0.00439	CcSEcCtD
Chloroquine—TNF—Overview of nanoparticle effects—PTGS2—skin cancer	0.000672	0.00933	CbGpPWpGaD
Chloroquine—Diarrhoea—Vemurafenib—skin cancer	0.00067	0.00436	CcSEcCtD
Chloroquine—Erythema multiforme—Temozolomide—skin cancer	0.000666	0.00434	CcSEcCtD
Chloroquine—Urticaria—Imiquimod—skin cancer	0.000663	0.00432	CcSEcCtD
Chloroquine—Abdominal pain—Imiquimod—skin cancer	0.00066	0.0043	CcSEcCtD
Chloroquine—TNF—Spinal Cord Injury—CSPG4—skin cancer	0.000658	0.00915	CbGpPWpGaD
Chloroquine—Tinnitus—Temozolomide—skin cancer	0.000657	0.00428	CcSEcCtD
Chloroquine—Vomiting—Vemurafenib—skin cancer	0.000623	0.00406	CcSEcCtD
Chloroquine—Alopecia—Temozolomide—skin cancer	0.000622	0.00405	CcSEcCtD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—TLR7—skin cancer	0.000621	0.00863	CbGpPWpGaD
Chloroquine—Rash—Vemurafenib—skin cancer	0.000617	0.00402	CcSEcCtD
Chloroquine—Headache—Vemurafenib—skin cancer	0.000613	0.004	CcSEcCtD
Chloroquine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00061	0.00397	CcSEcCtD
Chloroquine—Asthenia—Imiquimod—skin cancer	0.000599	0.0039	CcSEcCtD
Chloroquine—Confusional state—Bleomycin—skin cancer	0.000598	0.0039	CcSEcCtD
Chloroquine—Anaphylactic shock—Bleomycin—skin cancer	0.000593	0.00386	CcSEcCtD
Chloroquine—Pruritus—Imiquimod—skin cancer	0.000591	0.00385	CcSEcCtD
Chloroquine—Nausea—Vemurafenib—skin cancer	0.000582	0.00379	CcSEcCtD
Chloroquine—Thrombocytopenia—Bleomycin—skin cancer	0.000581	0.00378	CcSEcCtD
Chloroquine—Vision blurred—Temozolomide—skin cancer	0.000578	0.00376	CcSEcCtD
Chloroquine—Alopecia—Fluorouracil—skin cancer	0.000573	0.00374	CcSEcCtD
Chloroquine—Diarrhoea—Imiquimod—skin cancer	0.000571	0.00372	CcSEcCtD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.00057	0.00792	CbGpPWpGaD
Chloroquine—Anorexia—Bleomycin—skin cancer	0.000565	0.00368	CcSEcCtD
Chloroquine—Agitation—Temozolomide—skin cancer	0.000563	0.00367	CcSEcCtD
Chloroquine—Angioedema—Temozolomide—skin cancer	0.00056	0.00365	CcSEcCtD
Chloroquine—Pancytopenia—Docetaxel—skin cancer	0.000556	0.00362	CcSEcCtD
Chloroquine—Hypotension—Bleomycin—skin cancer	0.000554	0.00361	CcSEcCtD
Chloroquine—Neutropenia—Docetaxel—skin cancer	0.000547	0.00356	CcSEcCtD
Chloroquine—TLR9—Innate Immune System—TLR7—skin cancer	0.000546	0.00759	CbGpPWpGaD
Chloroquine—Thrombocytopenia—Dactinomycin—skin cancer	0.000542	0.00353	CcSEcCtD
Chloroquine—Vision blurred—Fluorouracil—skin cancer	0.000532	0.00347	CcSEcCtD
Chloroquine—Convulsion—Temozolomide—skin cancer	0.000531	0.00346	CcSEcCtD
Chloroquine—Vomiting—Imiquimod—skin cancer	0.000531	0.00346	CcSEcCtD
Chloroquine—Anorexia—Dactinomycin—skin cancer	0.000527	0.00344	CcSEcCtD
Chloroquine—Rash—Imiquimod—skin cancer	0.000526	0.00343	CcSEcCtD
Chloroquine—Headache—Imiquimod—skin cancer	0.000523	0.00341	CcSEcCtD
Chloroquine—Anxiety—Temozolomide—skin cancer	0.00052	0.00339	CcSEcCtD
Chloroquine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000517	0.00337	CcSEcCtD
Chloroquine—TLR9—Signaling Pathways—RHOU—skin cancer	0.000517	0.00718	CbGpPWpGaD
Chloroquine—Decreased appetite—Bleomycin—skin cancer	0.000516	0.00336	CcSEcCtD
Chloroquine—Confusional state—Temozolomide—skin cancer	0.000505	0.00329	CcSEcCtD
Chloroquine—Anaphylactic shock—Temozolomide—skin cancer	0.0005	0.00326	CcSEcCtD
Chloroquine—Nausea—Imiquimod—skin cancer	0.000496	0.00323	CcSEcCtD
Chloroquine—Thrombocytopenia—Temozolomide—skin cancer	0.00049	0.00319	CcSEcCtD
Chloroquine—Convulsion—Fluorouracil—skin cancer	0.000489	0.00319	CcSEcCtD
Chloroquine—Feeling abnormal—Bleomycin—skin cancer	0.000489	0.00318	CcSEcCtD
Chloroquine—Agranulocytosis—Docetaxel—skin cancer	0.000487	0.00317	CcSEcCtD
Chloroquine—Decreased appetite—Dactinomycin—skin cancer	0.000481	0.00313	CcSEcCtD
Chloroquine—Anorexia—Temozolomide—skin cancer	0.000477	0.00311	CcSEcCtD
Chloroquine—CYP1A1—PPARA activates gene expression—PLIN2—skin cancer	0.000474	0.00659	CbGpPWpGaD
Chloroquine—Urticaria—Bleomycin—skin cancer	0.000471	0.00307	CcSEcCtD
Chloroquine—Hepatitis—Docetaxel—skin cancer	0.000468	0.00305	CcSEcCtD
Chloroquine—Confusional state—Fluorouracil—skin cancer	0.000465	0.00303	CcSEcCtD
Chloroquine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.000464	0.00645	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Fluorouracil—skin cancer	0.000461	0.003	CcSEcCtD
Chloroquine—Feeling abnormal—Dactinomycin—skin cancer	0.000456	0.00297	CcSEcCtD
Chloroquine—Insomnia—Temozolomide—skin cancer	0.000453	0.00295	CcSEcCtD
Chloroquine—Thrombocytopenia—Fluorouracil—skin cancer	0.000451	0.00294	CcSEcCtD
Chloroquine—Visual impairment—Docetaxel—skin cancer	0.000451	0.00294	CcSEcCtD
Chloroquine—Erythema multiforme—Docetaxel—skin cancer	0.000443	0.00288	CcSEcCtD
Chloroquine—Anorexia—Fluorouracil—skin cancer	0.000439	0.00286	CcSEcCtD
Chloroquine—Abdominal pain—Dactinomycin—skin cancer	0.000437	0.00285	CcSEcCtD
Chloroquine—Decreased appetite—Temozolomide—skin cancer	0.000435	0.00283	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000434	0.00602	CbGpPWpGaD
Chloroquine—TLR9—IRS-mediated signalling—NRAS—skin cancer	0.000433	0.00602	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000432	0.00281	CcSEcCtD
Chloroquine—Hypotension—Fluorouracil—skin cancer	0.000431	0.00281	CcSEcCtD
Chloroquine—Asthenia—Bleomycin—skin cancer	0.000426	0.00277	CcSEcCtD
Chloroquine—TLR9—IRS-related events—NRAS—skin cancer	0.000421	0.00585	CbGpPWpGaD
Chloroquine—Pruritus—Bleomycin—skin cancer	0.00042	0.00273	CcSEcCtD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—NRAS—skin cancer	0.000417	0.0058	CbGpPWpGaD
Chloroquine—Insomnia—Fluorouracil—skin cancer	0.000417	0.00272	CcSEcCtD
Chloroquine—Alopecia—Docetaxel—skin cancer	0.000414	0.0027	CcSEcCtD
Chloroquine—Feeling abnormal—Temozolomide—skin cancer	0.000412	0.00269	CcSEcCtD
Chloroquine—TLR9—Insulin receptor signalling cascade—NRAS—skin cancer	0.000407	0.00565	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—NRAS—skin cancer	0.000407	0.00565	CbGpPWpGaD
Chloroquine—Decreased appetite—Fluorouracil—skin cancer	0.000401	0.00261	CcSEcCtD
Chloroquine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000398	0.00259	CcSEcCtD
Chloroquine—Urticaria—Temozolomide—skin cancer	0.000398	0.00259	CcSEcCtD
Chloroquine—Asthenia—Dactinomycin—skin cancer	0.000397	0.00259	CcSEcCtD
Chloroquine—Abdominal pain—Temozolomide—skin cancer	0.000396	0.00258	CcSEcCtD
Chloroquine—Feeling abnormal—Fluorouracil—skin cancer	0.00038	0.00247	CcSEcCtD
Chloroquine—Diarrhoea—Dactinomycin—skin cancer	0.000379	0.00247	CcSEcCtD
Chloroquine—Vomiting—Bleomycin—skin cancer	0.000377	0.00246	CcSEcCtD
Chloroquine—Rash—Bleomycin—skin cancer	0.000374	0.00244	CcSEcCtD
Chloroquine—TLR9—IRS-mediated signalling—KRAS—skin cancer	0.000373	0.00518	CbGpPWpGaD
Chloroquine—Urticaria—Fluorouracil—skin cancer	0.000366	0.00239	CcSEcCtD
Chloroquine—TNF—Overview of nanoparticle effects—IL6—skin cancer	0.000366	0.00509	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events—KRAS—skin cancer	0.000363	0.00504	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—KRAS—skin cancer	0.000359	0.00499	CbGpPWpGaD
Chloroquine—Asthenia—Temozolomide—skin cancer	0.000359	0.00234	CcSEcCtD
Chloroquine—Pruritus—Temozolomide—skin cancer	0.000354	0.00231	CcSEcCtD
Chloroquine—Convulsion—Docetaxel—skin cancer	0.000353	0.0023	CcSEcCtD
Chloroquine—Nausea—Bleomycin—skin cancer	0.000352	0.0023	CcSEcCtD
Chloroquine—Vomiting—Dactinomycin—skin cancer	0.000352	0.00229	CcSEcCtD
Chloroquine—TLR9—Insulin receptor signalling cascade—KRAS—skin cancer	0.00035	0.00486	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—KRAS—skin cancer	0.00035	0.00486	CbGpPWpGaD
Chloroquine—Rash—Dactinomycin—skin cancer	0.000349	0.00227	CcSEcCtD
Chloroquine—Diarrhoea—Temozolomide—skin cancer	0.000342	0.00223	CcSEcCtD
Chloroquine—TLR9—Signaling by Insulin receptor—NRAS—skin cancer	0.000338	0.00469	CbGpPWpGaD
Chloroquine—Confusional state—Docetaxel—skin cancer	0.000336	0.00219	CcSEcCtD
Chloroquine—TNF—MAPK Signaling Pathway—RASA1—skin cancer	0.000335	0.00466	CbGpPWpGaD
Chloroquine—Anaphylactic shock—Docetaxel—skin cancer	0.000333	0.00217	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000331	0.0046	CbGpPWpGaD
Chloroquine—Nausea—Dactinomycin—skin cancer	0.000329	0.00214	CcSEcCtD
Chloroquine—Pruritus—Fluorouracil—skin cancer	0.000326	0.00212	CcSEcCtD
Chloroquine—Thrombocytopenia—Docetaxel—skin cancer	0.000326	0.00212	CcSEcCtD
Chloroquine—TNF—Transcription factor regulation in adipogenesis—IL6—skin cancer	0.000326	0.00452	CbGpPWpGaD
Chloroquine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00032	0.00444	CbGpPWpGaD
Chloroquine—TLR9—Immune System—TLR7—skin cancer	0.000318	0.00442	CbGpPWpGaD
Chloroquine—Vomiting—Temozolomide—skin cancer	0.000318	0.00207	CcSEcCtD
Chloroquine—Anorexia—Docetaxel—skin cancer	0.000317	0.00207	CcSEcCtD
Chloroquine—TLR9—IRS-mediated signalling—HRAS—skin cancer	0.000317	0.0044	CbGpPWpGaD
Chloroquine—Rash—Temozolomide—skin cancer	0.000316	0.00206	CcSEcCtD
Chloroquine—Diarrhoea—Fluorouracil—skin cancer	0.000315	0.00205	CcSEcCtD
Chloroquine—Headache—Temozolomide—skin cancer	0.000313	0.00204	CcSEcCtD
Chloroquine—Hypotension—Docetaxel—skin cancer	0.000311	0.00203	CcSEcCtD
Chloroquine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—skin cancer	0.00031	0.0043	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events—HRAS—skin cancer	0.000308	0.00428	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—BRAF—skin cancer	0.000307	0.00427	CbGpPWpGaD
Chloroquine—TNF—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000307	0.00426	CbGpPWpGaD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—HRAS—skin cancer	0.000305	0.00424	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000304	0.00423	CbGpPWpGaD
Chloroquine—TLR9—IRS-mediated signalling—IL6—skin cancer	0.000303	0.00421	CbGpPWpGaD
Chloroquine—Insomnia—Docetaxel—skin cancer	0.000301	0.00196	CcSEcCtD
Chloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	0.0003	0.00417	CbGpPWpGaD
Chloroquine—TLR9—Insulin receptor signalling cascade—HRAS—skin cancer	0.000297	0.00413	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—HRAS—skin cancer	0.000297	0.00413	CbGpPWpGaD
Chloroquine—Nausea—Temozolomide—skin cancer	0.000297	0.00194	CcSEcCtD
Chloroquine—TLR9—IRS-related events—IL6—skin cancer	0.000295	0.0041	CbGpPWpGaD
Chloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	0.000295	0.0041	CbGpPWpGaD
Chloroquine—Vomiting—Fluorouracil—skin cancer	0.000293	0.00191	CcSEcCtD
Chloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—skin cancer	0.000292	0.00406	CbGpPWpGaD
Chloroquine—Rash—Fluorouracil—skin cancer	0.000291	0.00189	CcSEcCtD
Chloroquine—TLR9—Signaling by Insulin receptor—KRAS—skin cancer	0.000291	0.00404	CbGpPWpGaD
Chloroquine—Decreased appetite—Docetaxel—skin cancer	0.000289	0.00188	CcSEcCtD
Chloroquine—Headache—Fluorouracil—skin cancer	0.000289	0.00188	CcSEcCtD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000289	0.00401	CbGpPWpGaD
Chloroquine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000287	0.00187	CcSEcCtD
Chloroquine—TNF—IL27-mediated signaling events—IL6—skin cancer	0.000285	0.00396	CbGpPWpGaD
Chloroquine—TLR9—Insulin receptor signalling cascade—IL6—skin cancer	0.000285	0.00395	CbGpPWpGaD
Chloroquine—TLR9—IGF1R signaling cascade—IL6—skin cancer	0.000285	0.00395	CbGpPWpGaD
Chloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	0.000285	0.00395	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—FOXO4—skin cancer	0.000281	0.00391	CbGpPWpGaD
Chloroquine—TNF—Cytokines and Inflammatory Response—IL6—skin cancer	0.000276	0.00384	CbGpPWpGaD
Chloroquine—Feeling abnormal—Docetaxel—skin cancer	0.000274	0.00179	CcSEcCtD
Chloroquine—Nausea—Fluorouracil—skin cancer	0.000274	0.00178	CcSEcCtD
Chloroquine—Abdominal pain—Docetaxel—skin cancer	0.000263	0.00171	CcSEcCtD
Chloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—skin cancer	0.000262	0.00364	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000258	0.00358	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTCH2—skin cancer	0.000252	0.00351	CbGpPWpGaD
Chloroquine—TLR9—Signaling by Insulin receptor—HRAS—skin cancer	0.000247	0.00343	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—SCN10A—skin cancer	0.000246	0.00342	CbGpPWpGaD
Chloroquine—TNF—amb2 Integrin signaling—IL6—skin cancer	0.000241	0.00335	CbGpPWpGaD
Chloroquine—Asthenia—Docetaxel—skin cancer	0.000239	0.00156	CcSEcCtD
Chloroquine—GSTA2—Metabolism—PLIN2—skin cancer	0.000238	0.0033	CbGpPWpGaD
Chloroquine—TLR9—Signaling by Insulin receptor—IL6—skin cancer	0.000236	0.00328	CbGpPWpGaD
Chloroquine—Pruritus—Docetaxel—skin cancer	0.000235	0.00153	CcSEcCtD
Chloroquine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—skin cancer	0.00023	0.00319	CbGpPWpGaD
Chloroquine—Diarrhoea—Docetaxel—skin cancer	0.000228	0.00148	CcSEcCtD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000222	0.00308	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—CDKN2A—skin cancer	0.000219	0.00304	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—CDK4—skin cancer	0.000218	0.00303	CbGpPWpGaD
Chloroquine—TNF—IL23-mediated signaling events—IL6—skin cancer	0.000215	0.00298	CbGpPWpGaD
Chloroquine—Vomiting—Docetaxel—skin cancer	0.000212	0.00138	CcSEcCtD
Chloroquine—Rash—Docetaxel—skin cancer	0.00021	0.00137	CcSEcCtD
Chloroquine—Headache—Docetaxel—skin cancer	0.000208	0.00136	CcSEcCtD
Chloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	0.000205	0.00284	CbGpPWpGaD
Chloroquine—TLR9—Toll-Like Receptors Cascades—IL6—skin cancer	0.000202	0.00281	CbGpPWpGaD
Chloroquine—Nausea—Docetaxel—skin cancer	0.000198	0.00129	CcSEcCtD
Chloroquine—TNF—Selenium Micronutrient Network—PTGS2—skin cancer	0.000197	0.00274	CbGpPWpGaD
Chloroquine—TNF—TWEAK Signaling Pathway—IL6—skin cancer	0.000194	0.0027	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	0.000193	0.00268	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—CSPG4—skin cancer	0.000192	0.00266	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—GLI2—skin cancer	0.000191	0.00266	CbGpPWpGaD
Chloroquine—TNF—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000189	0.00262	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—MC1R—skin cancer	0.000182	0.00254	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	0.000182	0.00253	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—GLI1—skin cancer	0.00018	0.0025	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SUFU—skin cancer	0.000171	0.00237	CbGpPWpGaD
Chloroquine—CYP1A1—Arachidonic acid metabolism—PTGS2—skin cancer	0.00017	0.00236	CbGpPWpGaD
Chloroquine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	0.00017	0.00236	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	0.000166	0.00231	CbGpPWpGaD
Chloroquine—TNF—Vitamin B12 Metabolism—IL6—skin cancer	0.000166	0.00231	CbGpPWpGaD
Chloroquine—TNF—TGF-beta Receptor Signaling—HRAS—skin cancer	0.000166	0.0023	CbGpPWpGaD
Chloroquine—TLR9—Immune System—FOXO4—skin cancer	0.000164	0.00228	CbGpPWpGaD
Chloroquine—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	0.000156	0.00217	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—PTGS2—skin cancer	0.000156	0.00217	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000148	0.00206	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—NRAS—skin cancer	0.000148	0.00206	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—TP53—skin cancer	0.000148	0.00205	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—BRAF—skin cancer	0.000145	0.00202	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—RASA1—skin cancer	0.000141	0.00197	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000141	0.00197	CbGpPWpGaD
Chloroquine—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	0.000141	0.00196	CbGpPWpGaD
Chloroquine—TNF—Folate Metabolism—IL6—skin cancer	0.000135	0.00188	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000133	0.00185	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—ENO2—skin cancer	0.00013	0.00181	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SHH—skin cancer	0.00013	0.00181	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—RASA1—skin cancer	0.000129	0.0018	CbGpPWpGaD
Chloroquine—TNF—Alzheimers Disease—TP53—skin cancer	0.000128	0.00178	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—KRAS—skin cancer	0.000127	0.00177	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000127	0.00177	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000127	0.00176	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—SMO—skin cancer	0.000123	0.00171	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTCH1—skin cancer	0.000123	0.00171	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—skin cancer	0.000122	0.00169	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000122	0.00169	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—PTGER4—skin cancer	0.00012	0.00167	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000117	0.00162	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—HRAS—skin cancer	0.000108	0.0015	CbGpPWpGaD
Chloroquine—TNF—Selenium Micronutrient Network—IL6—skin cancer	0.000107	0.00149	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000106	0.00147	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—FOXO4—skin cancer	0.000106	0.00147	CbGpPWpGaD
Chloroquine—TNF—TNF alpha Signaling Pathway—IL6—skin cancer	0.000104	0.00144	CbGpPWpGaD
Chloroquine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000103	0.00144	CbGpPWpGaD
Chloroquine—TNF—Toll-like Receptor Signaling Pathway—IL6—skin cancer	9.54e-05	0.00133	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—NRAS—skin cancer	9.36e-05	0.0013	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—TP53—skin cancer	9.28e-05	0.00129	CbGpPWpGaD
Chloroquine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.17e-05	0.00127	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—NRAS—skin cancer	9.14e-05	0.00127	CbGpPWpGaD
Chloroquine—TNF—Spinal Cord Injury—IL6—skin cancer	8.49e-05	0.00118	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—KRAS—skin cancer	8.05e-05	0.00112	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—KRAS—skin cancer	7.87e-05	0.00109	CbGpPWpGaD
Chloroquine—TNF—Adipogenesis—IL6—skin cancer	7.86e-05	0.00109	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—ERCC2—skin cancer	7.57e-05	0.00105	CbGpPWpGaD
Chloroquine—TNF—Apoptosis—TP53—skin cancer	7.46e-05	0.00104	CbGpPWpGaD
Chloroquine—TNF—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	7.45e-05	0.00103	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	7.1e-05	0.000987	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TERT—skin cancer	7.08e-05	0.000984	CbGpPWpGaD
Chloroquine—TNF—MAPK Signaling Pathway—TP53—skin cancer	6.99e-05	0.000972	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—CDK4—skin cancer	6.94e-05	0.000964	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—HRAS—skin cancer	6.85e-05	0.000951	CbGpPWpGaD
Chloroquine—TNF—SIDS Susceptibility Pathways—IL6—skin cancer	6.79e-05	0.000944	CbGpPWpGaD
Chloroquine—TLR9—Innate Immune System—IL6—skin cancer	6.55e-05	0.00091	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	6.51e-05	0.000904	CbGpPWpGaD
Chloroquine—TNF—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	6.31e-05	0.000877	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PLIN2—skin cancer	6e-05	0.000834	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PLIN2—skin cancer	5.67e-05	0.000788	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—BRAF—skin cancer	5.61e-05	0.000779	CbGpPWpGaD
Chloroquine—TLR9—Immune System—NRAS—skin cancer	5.45e-05	0.000757	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PLIN2—skin cancer	5.2e-05	0.000722	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—CSPG4—skin cancer	4.84e-05	0.000672	CbGpPWpGaD
Chloroquine—TLR9—Immune System—KRAS—skin cancer	4.69e-05	0.000652	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.65e-05	0.000646	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—CSPG4—skin cancer	4.57e-05	0.000635	CbGpPWpGaD
Chloroquine—GSTA2—Metabolism—PTGS2—skin cancer	4.54e-05	0.000631	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PLIN2—skin cancer	4.53e-05	0.000629	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PLIN2—skin cancer	4.27e-05	0.000593	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—CSPG4—skin cancer	4.19e-05	0.000582	CbGpPWpGaD
Chloroquine—TLR9—Immune System—HRAS—skin cancer	3.99e-05	0.000554	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—NRAS—skin cancer	3.86e-05	0.000536	CbGpPWpGaD
Chloroquine—TLR9—Immune System—IL6—skin cancer	3.82e-05	0.00053	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—CSPG4—skin cancer	3.65e-05	0.000507	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—NRAS—skin cancer	3.52e-05	0.00049	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—CSPG4—skin cancer	3.44e-05	0.000478	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—KRAS—skin cancer	3.32e-05	0.000461	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ENO2—skin cancer	3.29e-05	0.000457	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.11e-05	0.000433	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ENO2—skin cancer	3.11e-05	0.000432	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—KRAS—skin cancer	3.03e-05	0.000421	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ENO2—skin cancer	2.85e-05	0.000396	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—HRAS—skin cancer	2.82e-05	0.000392	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PLIN2—skin cancer	2.79e-05	0.000388	CbGpPWpGaD
Chloroquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.77e-05	0.000384	CbGpPWpGaD
Chloroquine—TNF—Developmental Biology—IL6—skin cancer	2.7e-05	0.000375	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—TP53—skin cancer	2.7e-05	0.000374	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—HRAS—skin cancer	2.58e-05	0.000358	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ENO2—skin cancer	2.48e-05	0.000345	CbGpPWpGaD
Chloroquine—TLR9—Signaling Pathways—IL6—skin cancer	2.47e-05	0.000343	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.43e-05	0.000338	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ENO2—skin cancer	2.34e-05	0.000325	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—CSPG4—skin cancer	2.25e-05	0.000313	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.23e-05	0.00031	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—ERCC2—skin cancer	1.91e-05	0.000265	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—ERCC2—skin cancer	1.81e-05	0.000251	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—ERCC2—skin cancer	1.66e-05	0.00023	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ENO2—skin cancer	1.53e-05	0.000212	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—ERCC2—skin cancer	1.44e-05	0.0002	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—ERCC2—skin cancer	1.36e-05	0.000189	CbGpPWpGaD
Chloroquine—CYP3A5—Metabolism—PTGS2—skin cancer	1.15e-05	0.000159	CbGpPWpGaD
Chloroquine—CYP1A1—Metabolism—PTGS2—skin cancer	1.08e-05	0.00015	CbGpPWpGaD
Chloroquine—CYP2C8—Metabolism—PTGS2—skin cancer	9.92e-06	0.000138	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—ERCC2—skin cancer	8.88e-06	0.000123	CbGpPWpGaD
Chloroquine—ABCB1—Metabolism—PTGS2—skin cancer	8.65e-06	0.00012	CbGpPWpGaD
Chloroquine—CYP2D6—Metabolism—PTGS2—skin cancer	8.15e-06	0.000113	CbGpPWpGaD
Chloroquine—CYP3A4—Metabolism—PTGS2—skin cancer	5.33e-06	7.4e-05	CbGpPWpGaD
